Stericycle price target lowered to $50 from $57 at Truist

Truist lowered the firm’s price target on Stericycle to $50 from $57 and keeps a Hold rating on the shares. The company reported a “mixed” Q1 and the stock slumped amid slightly weaker organic revenue growth and cash outflows that were greater than the Street anticipated, the analyst tells investors in a research note. Stericycle margins should reap increased benefit from headcount reductions and ERP-driven efficiencies over the coming quarters, the firm added.